Drug factory · FDA FEI 1222181
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
1 Burtt Rd, Andover, MA, United States
Problems found, fixed voluntarily at FDA's last inspection, Apr 8, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2009: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 8, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 13, 2023 | No problems found | Drug Quality Assurance | — |
| Sep 30, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 28, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 4, 2009 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.